Posts
- Category: Articles (continued)
- Chief Huntington’s disease drug hunter: ‘every confidence first treatments’ in the works
- CIRM awards $25M in grants for stem cell research
- Cittadinanzattiva su Piano nazionale delle malattie rare: impegno a garantire entro 30 giorni l’elenco aggiornato e previsione di risorse aggiuntive.
- Clinical Development of VX15/2503 Anti-Semaphorin 4D Antibody as a Potential Treatment for Huntington’s Disease
- clinical trial (phase 2 trial of VX15 antibody in Huntington’s disease) at the 2015 Huntington Study Group Annual Meeting in Tampa, Fl.
- CME4HD online
- Colmare il divario di cura: nuove linee-guida per la cura della Malattia di Huntington
- Comprehensive Huntington's Disease Clinic Opens at Northwestern Medicine
- Comunicato AICH - Roma Onlus
- CON LE STAMINALI DAL MIDOLLO COMBATTEREMO IL PARKINSON
- Control of KMO gene expression in Alzheimer and Huntington diseases
- Cost-Effective Way to Diagnose Huntington's Disease Coming to Microsoft's Imagine Cup
- Could DBS Provide Relief for Huntington’s Disease?
- Critical Path Institute and CHDI Foundation, Inc., establish a consortium to expedite approval of Huntington’s disease therapeutics
- Cure for Huntington’s disease within reach
- DATA NOW AVAILABLE
- Defending against the Enemy Within
- Des tissus sains greffés au cerveau de personnes souffrant de la maladie de Huntington développent eux aussi des signes de la maladie
- Deutetrabenazine for Treatment of Chorea in Huntington Disease
- Dieci regole d'oro per leggere un articolo scientifico sulle novità della ricerca
- Dietary Choices May Affect Huntington's Disease Onset
- Discovery could aid in development of treatments for fatal brain disease
- Disease in a dish approach could aid Huntington's disease discovery
- Disease research: Rare insights
- Dithiol-based compounds maintain the expression of the antioxidant protein Peroxiredoxin 1 which counteracts the toxicity of mutant Huntingtin
- Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
- Dr. Leslie Thompson Selected as First Editor of New Huntington’s Disease Journal
- Drosophila center hits historic milestone with chromosome deletions
- Drug Reduces Brain Changes, Motor Deficits Associated With Huntington’s Disease
- Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice
- Editing the genome with high precision
- Educate, Inform & Inspire Global Awareness by Sharing 'Stem Cells Offer Hope
- EHDN is launching the new website www.ehdn.org
- EHDN NEWS
- EHDN NEWS
- EHDN News
- EHDN News
- Eisai and Galenea Partner to Develop Drugs that Restore Synaptic Function
- Elena Cattaneo is Stem Cell Person of the Year!
- Elena Cattaneo nominata senatrice a vita
- Endurance training as a treatment approach for Huntington’s disease
- ENROLL NEW WEBSITE
- Enroll-HD autumn 2014 News
- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data
- Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017
- European Commission Approves PBT2 Orphan Designation for Huntington’s Disease
- Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
- Evolution and function of CAG/polyglutamine repeats in protein–protein interaction networks
- Evotec and CHDI Foundation expand ongoing collaboration to fight Huntington's disease using Evotec's expanded capabilities and footprint
- Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease
Plugin by dagondesign.com
